ArticlePharmaceutics2023

Enhancing the Treatment of Uncontrolled Inflammation through the Targeted Delivery of TPCA-1-Loaded Nanoparticles.

Zhaozhao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.